Polaris Market Research today released findings from its latest industry report, projecting the U.S. Vaccine Storage & Packaging market to expand from USD 8.63 Billion in 2024 to USD 26.01 Billion by 2034, registering a CAGR of 11.68% across the forecast period. The report profiles 12 leading companies operating across the market's key segments and regions.

Analyst Commentary on U.S. Vaccine Storage & Packaging Market Growth

"Cold chain integrity has become a board-level concern for U.S. healthcare providers, and that is translating directly into capital spending on storage and packaging infrastructure" said a senior analyst at Polaris Market Research. "Distributors and retailers alike are investing in smarter, more traceable systems to protect vaccine potency from the warehouse to the point of administration"

Key Growth Drivers, Major Companies and Segments Covered

Growth Drivers: rising U.S. healthcare spending, which reached $4.9 trillion in 2023, a high incidence of chronic disease that is driving expanded vaccination campaigns, and growing government investment in immunization programs are the primary forces behind the market's expansion, alongside rising demand for cold chain logistics and temperature-controlled packaging. In September 2022, Becton, Dickinson and Company introduced a next-generation glass prefillable syringe designed to raise the performance bar for vaccine packaging.

Major Companies Covered: 

• B Medical Systems
• Becton Dickinson
• Darwin Chambers
• Gerresheimer AG
• IC Biomedical
• SCHOTT Pharma AG & Co. KGaA
• SiO2 Materials Science
• Stevanato Group
• Thermo Fisher Scientific Inc.
• TruMed Systems

Request for a sample copy of this research report @

https://www.polarismarketresearch.com/industry-analysis/us-vaccine-storage-and-packaging-market 

Segments Covered: By Function (Storage, Packaging), By End Use (Retailers, Forwarding & Clearing Agents, Distributors, Others).

Recent Developments in the U.S. Vaccine Storage & Packaging Market

• September 2022: Becton, Dickinson and Company launched a next-generation glass prefillable syringe (PFS) built to set a new performance standard for vaccine packaging.
• Ongoing: CDC-guided cold chain compliance continues to push hospitals, clinics, and immunization centers toward ultra-low temperature freezers and IoT-enabled monitoring systems.

Market Snapshot: Storage Leads, Retailers Set to Accelerate

The storage segment held the largest share of the U.S. vaccine storage & packaging market in 2024, driven by mass vaccination campaigns and CDC compliance requirements. Distributors currently dominate the end-use landscape given their central role in temperature-controlled delivery, but the retailers segment — spanning pharmacies and retail health clinics — is set to grow fastest as seasonal flu shots, COVID-19 boosters, and other adult immunizations increasingly move to the point of retail care.

Why It Matters for Teams Evaluating Cold Chain Investment

For stakeholders researching vaccine storage and packaging market forecast, the underlying Polaris Market Research report benchmarks U.S. Vaccine Storage & Packaging market share, company positioning, and segment-level forecasts to support sourcing, partnership, and investment decisions through 2034.

Conclusion

As chronic disease prevalence rises and immunization programs expand, U.S. vaccine storage and packaging infrastructure is shifting from a compliance requirement to a strategic investment priority. With the market projected to triple by 2034, distributors, retailers, and packaging innovators that can demonstrate cold chain reliability and traceability are best positioned to capture the next decade of growth.

More Trending Latest Reports By Polaris Market Research:

Plant-Based Oils Market

Dry Van Container Market

Machine Risk Assessment Market

Growing Prevalence of Brain Aneurysm to Boost Growth

Extruded Polystyrene Market

Extruded Polystyrene Market

Liver Cancer Market

PLGA Market

Solid State Transformers Market